| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Williams Eddie is a Director at BCAB, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $440K at current prices.
Williams Eddie's largest disclosed position is in GYRE as Director, worth about $232K. Net of sales, the recent Form 4 record there shows accumulation of 2,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2020 | GYRE Gyre Therapeutics, Inc. | Director | Buy | 2,000 | $5.78 | $11,560.00 | +22.6% |